Cargando…

Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis

OBJECTIVES: Respiratory co‐infections have the potential to affect the diagnosis and treatment of COVID‐19 patients. This meta‐analysis was performed to analyze the prevalence of respiratory pathogens (viruses and atypical bacteria) in COVID‐19 patients. METHODS: This review was consistent with Pref...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Bennett, Rothrock, Ava N., Swetland, Sarah, Andris, Halle, Davis, Phil, Rothrock, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323310/
https://www.ncbi.nlm.nih.gov/pubmed/32838380
http://dx.doi.org/10.1002/emp2.12128
_version_ 1783551767125950464
author Davis, Bennett
Rothrock, Ava N.
Swetland, Sarah
Andris, Halle
Davis, Phil
Rothrock, Steven G.
author_facet Davis, Bennett
Rothrock, Ava N.
Swetland, Sarah
Andris, Halle
Davis, Phil
Rothrock, Steven G.
author_sort Davis, Bennett
collection PubMed
description OBJECTIVES: Respiratory co‐infections have the potential to affect the diagnosis and treatment of COVID‐19 patients. This meta‐analysis was performed to analyze the prevalence of respiratory pathogens (viruses and atypical bacteria) in COVID‐19 patients. METHODS: This review was consistent with Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA). Searched databases included: PubMed, EMBASE, Web of Science, Google Scholar, and grey literature. Studies with a series of SARS‐CoV‐2‐positive patients with additional respiratory pathogen testing were included. Independently, 2 authors extracted data and assessed quality of evidence across all studies using Cochrane's Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology and within each study using the Newcastle Ottawa scale. Data extraction and quality assessment disagreements were settled by a third author. Pooled prevalence of co‐infections was calculated using a random‐effects model with univariate meta‐regression performed to assess the effect of study subsets on heterogeneity. Publication bias was evaluated using funnel plot inspection, Begg's correlation, and Egger's test. RESULTS: Eighteen retrospective cohorts and 1 prospective study were included. Pooling of data (1880 subjects) showed an 11.6% (95% confidence interval [CI] = 6.9–17.4, I (2) = 0.92) pooled prevalence of respiratory co‐pathogens. Studies with 100% co‐pathogen testing (1210 subjects) found a pooled prevalence of 16.8% (95% CI = 8.1–27.9, I (2) = 0.95) and studies using serum antibody tests (488 subjects) found a pooled prevalence of 26.8% (95%, CI = 7.9–51.9, I (2) = 0.97). Meta‐regression found no moderators affecting heterogeneity. CONCLUSION: Co‐infection with respiratory pathogens is a common and potentially important occurrence in patients with COVID‐19. Knowledge of the prevalence and type of co‐infections may have diagnostic and management implications.
format Online
Article
Text
id pubmed-7323310
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73233102020-06-29 Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis Davis, Bennett Rothrock, Ava N. Swetland, Sarah Andris, Halle Davis, Phil Rothrock, Steven G. J Am Coll Emerg Physicians Open Infectious Disease OBJECTIVES: Respiratory co‐infections have the potential to affect the diagnosis and treatment of COVID‐19 patients. This meta‐analysis was performed to analyze the prevalence of respiratory pathogens (viruses and atypical bacteria) in COVID‐19 patients. METHODS: This review was consistent with Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA). Searched databases included: PubMed, EMBASE, Web of Science, Google Scholar, and grey literature. Studies with a series of SARS‐CoV‐2‐positive patients with additional respiratory pathogen testing were included. Independently, 2 authors extracted data and assessed quality of evidence across all studies using Cochrane's Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology and within each study using the Newcastle Ottawa scale. Data extraction and quality assessment disagreements were settled by a third author. Pooled prevalence of co‐infections was calculated using a random‐effects model with univariate meta‐regression performed to assess the effect of study subsets on heterogeneity. Publication bias was evaluated using funnel plot inspection, Begg's correlation, and Egger's test. RESULTS: Eighteen retrospective cohorts and 1 prospective study were included. Pooling of data (1880 subjects) showed an 11.6% (95% confidence interval [CI] = 6.9–17.4, I (2) = 0.92) pooled prevalence of respiratory co‐pathogens. Studies with 100% co‐pathogen testing (1210 subjects) found a pooled prevalence of 16.8% (95% CI = 8.1–27.9, I (2) = 0.95) and studies using serum antibody tests (488 subjects) found a pooled prevalence of 26.8% (95%, CI = 7.9–51.9, I (2) = 0.97). Meta‐regression found no moderators affecting heterogeneity. CONCLUSION: Co‐infection with respiratory pathogens is a common and potentially important occurrence in patients with COVID‐19. Knowledge of the prevalence and type of co‐infections may have diagnostic and management implications. John Wiley and Sons Inc. 2020-06-19 /pmc/articles/PMC7323310/ /pubmed/32838380 http://dx.doi.org/10.1002/emp2.12128 Text en © 2020 The Authors. JACEP Open published by Wiley Periodicals LLC on behalf of the American College of Emergency Physicians. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Infectious Disease
Davis, Bennett
Rothrock, Ava N.
Swetland, Sarah
Andris, Halle
Davis, Phil
Rothrock, Steven G.
Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis
title Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis
title_full Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis
title_fullStr Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis
title_full_unstemmed Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis
title_short Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis
title_sort viral and atypical respiratory co‐infections in covid‐19: a systematic review and meta‐analysis
topic Infectious Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323310/
https://www.ncbi.nlm.nih.gov/pubmed/32838380
http://dx.doi.org/10.1002/emp2.12128
work_keys_str_mv AT davisbennett viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis
AT rothrockavan viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis
AT swetlandsarah viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis
AT andrishalle viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis
AT davisphil viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis
AT rothrocksteveng viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis